Models of coxsackievirus-B3-induced myocarditis

Recent advances

DeLisa Fairweather, Noel R. Rose

Research output: Contribution to journalArticle

Abstract

Currently, animal models are available that closely resemble human myocarditis. Coxsackievirus B3 (CVB3)-induced myocarditis models fall into two major categories: direct viral damage models and virus-triggered autoimmune models. Debate focuses on whether CVB3 can cause autoimmune heart disease or whether myocardial inflammation is due to direct damage or persistence of virus. Recent findings strengthen the argument that CVB3 triggers autoimmune myocarditis in mice without the requirement for active viral replication.

Original languageEnglish (US)
Pages (from-to)381-386
Number of pages6
JournalDrug Discovery Today: Disease Models
Volume1
Issue number4
DOIs
StatePublished - Dec 2004

Fingerprint

Enterovirus
Myocarditis
Viruses
Autoimmune Diseases
Heart Diseases
Animal Models
Inflammation

ASJC Scopus subject areas

  • Drug Discovery
  • Molecular Medicine

Cite this

Models of coxsackievirus-B3-induced myocarditis : Recent advances. / Fairweather, DeLisa; Rose, Noel R.

In: Drug Discovery Today: Disease Models, Vol. 1, No. 4, 12.2004, p. 381-386.

Research output: Contribution to journalArticle

Fairweather, DeLisa ; Rose, Noel R. / Models of coxsackievirus-B3-induced myocarditis : Recent advances. In: Drug Discovery Today: Disease Models. 2004 ; Vol. 1, No. 4. pp. 381-386.
@article{cf247c3283f04173801739d36d4df541,
title = "Models of coxsackievirus-B3-induced myocarditis: Recent advances",
abstract = "Currently, animal models are available that closely resemble human myocarditis. Coxsackievirus B3 (CVB3)-induced myocarditis models fall into two major categories: direct viral damage models and virus-triggered autoimmune models. Debate focuses on whether CVB3 can cause autoimmune heart disease or whether myocardial inflammation is due to direct damage or persistence of virus. Recent findings strengthen the argument that CVB3 triggers autoimmune myocarditis in mice without the requirement for active viral replication.",
author = "DeLisa Fairweather and Rose, {Noel R.}",
year = "2004",
month = "12",
doi = "10.1016/j.ddmod.2004.11.003",
language = "English (US)",
volume = "1",
pages = "381--386",
journal = "Drug Discovery Today: Disease Models",
issn = "1740-6757",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Models of coxsackievirus-B3-induced myocarditis

T2 - Recent advances

AU - Fairweather, DeLisa

AU - Rose, Noel R.

PY - 2004/12

Y1 - 2004/12

N2 - Currently, animal models are available that closely resemble human myocarditis. Coxsackievirus B3 (CVB3)-induced myocarditis models fall into two major categories: direct viral damage models and virus-triggered autoimmune models. Debate focuses on whether CVB3 can cause autoimmune heart disease or whether myocardial inflammation is due to direct damage or persistence of virus. Recent findings strengthen the argument that CVB3 triggers autoimmune myocarditis in mice without the requirement for active viral replication.

AB - Currently, animal models are available that closely resemble human myocarditis. Coxsackievirus B3 (CVB3)-induced myocarditis models fall into two major categories: direct viral damage models and virus-triggered autoimmune models. Debate focuses on whether CVB3 can cause autoimmune heart disease or whether myocardial inflammation is due to direct damage or persistence of virus. Recent findings strengthen the argument that CVB3 triggers autoimmune myocarditis in mice without the requirement for active viral replication.

UR - http://www.scopus.com/inward/record.url?scp=23744516063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23744516063&partnerID=8YFLogxK

U2 - 10.1016/j.ddmod.2004.11.003

DO - 10.1016/j.ddmod.2004.11.003

M3 - Article

VL - 1

SP - 381

EP - 386

JO - Drug Discovery Today: Disease Models

JF - Drug Discovery Today: Disease Models

SN - 1740-6757

IS - 4

ER -